Business description
Neogen Corporation (Nasdaq: NEOG) develops and markets products dedicated to food and animal safety. Neogen’s Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
Management board & Supervisory board
| CEO |
| John Adent |
| Management board |
| David Naemura, Amy M. Rocklin, Dr. Jason W. Lilly, Dr. Robert S. Donofrio, Jerome Hagedorn, Julie L. Mann, Byoung-Ik Sohn, Matt Mittino |
| Supervisory board |
| James C. Borel, Aashima Gupta, Catherine E. Woteki, James P. Tobin, Jeffrey Capello, Ralph A. Rodriguez, Ronald Green, William T. Boehm |
Company data
| Name: |
Neogen Corp. |
| Address: |
620 Lesher Place,Lansing, Michigan 48912, USA |
| Phone: |
+1-517-372-9200 |
| Fax: |
+1-517-372-2006 |
| E-mail: |
corporate@neogen.com
|
| Internet: |
www.neogen.com |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
31/05 |
| Free Float: |
60.89% |
| IPO date: |
- |
Investor relations
| Name: |
Steven J. Quinlan |
| IR phone: |
+1-517-372-2280 |
| IR Fax: |
- |
| IR e-mail: |
ir@neogen.com
|
